Vaccine-preventable diseases and immunization

Young_boy_in_Sudan_receives_vaccination

WHO welcomes global health funding for malaria vaccine

The world’s first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa as funding has now been secured for the initial phase of the programme and vaccinations are due to begin in 2018.

The vaccine, known as RTS,S, acts against P. falciparum, the most deadly malaria parasite globally, and the most prevalent in Africa. Advanced clinical trials have shown RTS,S to provide partial protection against malaria in young children.

RTS,S was developed through a partnership between GlaxoSmithKline and the PATH Malaria Vaccine Initiative (MVI), with support from the Bill & Melinda Gates Foundation and from a network of African research centres.

Read more about global health funding for malaria vaccine

News

23 June 2016 -- The Gavi Vaccine Alliance has announced that it will support a WHO-coordinated pilot programme for the malaria vaccine RTS,S/AS01 (RTS,S). In a statement issued today, GAVI...

» Read the full story
Region shows strong commitment to World Immunization Week, 24–30 April 2015

In the last week of April 2015, the Region witnessed remarkable commitment and the strong leadership of Member States in observing World Immunization Week. Since commencement of Immunization Week events...

» Read the full story

In focus

28 February 2016 — The Ministerial Conference on Immunization in Africa, hosted by the World Health Organization’s Regional Offices for Africa and for the Eastern Mediterranean, in conjunction with the...

» Read the full story

Events

World Immunization Week – celebrated in the last week of April – aims to promote the use of vaccines to protect people of all ages against disease. Immunization saves millions...

» Read the full story